期刊文献+

糖耐量受损人群动脉粥样硬化与炎症因子间关系的研究 被引量:2

A study on the relationship between atherosclerosis and inflammatory factors in subjects with impaired glucose tolerant
下载PDF
导出
摘要 目的研究巨噬细胞移动抑制因子(MIF)、肿瘤坏死因子(TNFα)、C反应蛋白(CRP)在糖耐量受损(IGT)伴动脉粥样硬化(AS)中的作用。方法采用酶联免疫法或核素放免法检测IGT伴AS组、IGT不伴AS组和正常对照组血清MIF、TNFα和CRP的水平。应用超声检测颈动脉内膜中层厚度和动脉内径。结果IGT不伴AS组和IGT伴AS组的炎症因子水平高于正常对照组(P<0.05、P<0.01),IGT伴有AS的炎症因子的水平明显高于IGT不伴AS组(P<0.05)。炎症因子之间以及炎症因子与颈动脉内膜中层厚度、颈动脉的内径之间存在着明显的正相关。多元线性回归分析提示MIF和CRP可能是颈动脉内膜中层增厚的重要影响因素。结论炎症因子(MIF、TNFα、CRP)的过度表达可能参与了IGT和AS,这提示IGT和AS存在炎症状态。 Objective To study the relationship between atherosclerosis and inflammatory factors: Macrophage migration inhibitory factor( MIF), Tumor necrosis factor-α (TNF-α), C-Reactive Protein (CRP) in subjects with impaired glucose tolerant. Methods The levels of plasma MIF, TNF-α, CRP in three groups (IGT without AS groups.IGT with AS groups and control groups) were examined by the method of ELISA and RIA. Ultrasound was applied to scan carotid arteries intimae-media thickness and arteries dilatation. Results The levels of inflammatory factors were shown higher in IGT without AS groups and IGT with AS groups than those of control groups ( P 〈 0. 05, P 〈0. 01 ), the levels of inflammatory factors were shown higher in IGT with AS groups than those of IGT without AS groups ( P 〈 0. 05 ). There was positive correlation among inflammatory factors , and there was also positive correlation between inflammatory factors and carotid arteries intimae-media thickness.arteries dilatation. Muhivariable analysis showed the importance factors of carotid arteries intimae-media thickness were MIF and CRP. Conclusion The levels of over expressed inflammatory factors( MIF, TNF-α, CRP)in serum may take part in AS in subjets with impaired glucose tolerant. This means that it has inflammatory conditions in IGT and AS.
出处 《安徽医科大学学报》 CAS 北大核心 2005年第6期572-574,共3页 Acta Universitatis Medicinalis Anhui
基金 中央保健专项资金资助课题(编号:B037)
关键词 葡萄糖耐受不良 动脉硬化 巨噬细胞游走抑制因子 肿瘤坏死因子 C反应蛋白 glucose intolerance atherosclerosis macrophage migration inhibitory factors tumor ncrosis factor C-reactive protein
  • 相关文献

参考文献6

  • 1施仲伟,沈蓓蓓,沈戈,林淑英,龚兰生.老年患者颈动脉粥样硬化的发生率及危险因素[J].中华内科杂志,1996,35(1):25-27. 被引量:42
  • 2Bourn DM. The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus. Diabetic Med, 1996; 13(11):938-45.
  • 3陈海冰,叶山东,陈燕,杨明功,任安,莫蔚林,邢学农,李素梅,陈超,陈若平,荆春燕.肥胖症、糖耐量减退、2型糖尿病的真胰岛素和前胰岛素水平的变化及其意义[J].安徽医科大学学报,2003,38(1):47-50. 被引量:2
  • 4Muller S, Martin S, Koenig W et al. Inflammatory mediators in IGT. Diabetologia, 2002;45(6): 805 - 12.
  • 5Junichi Hirokawa, Shinji Sakaue, Seiichi Tagami et al. Identification of Macrophage Migration Inhibitory Factor in Adipose Tissue and Its Induction by Tumor Necrosis Factor-α. Biochemical and Biophysical research communications, 1997; 235(1):94 - 8.
  • 6Wang TJ, Larson MG, Levy D et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women:the Framingham Heart Study. Circulation, 2002; 106(10):1189-91.

二级参考文献9

  • 1[1]Cederholm J,Wibell K. Insulin release and peripheral sensitivity at the oral glucose tolerence test. Diabetes Res Clin Pract,1990;10(1):167~75
  • 2[3]Taniguchi A, Nakai Y, Fukushima H et al. Pathogenic factor responsible for glucose tolerance in patients with NIDDM. Diabetes,1992;41(10):1540~8
  • 3[4]Nagi DK, Konwler WC,Mohamed AV et al. Intact proinsulin, del 31,32 proinsulin, and specific insulin concentration among nondiabetic subjects in populations at varying risk of type 2 diabetes. Diabetes Care,1998;21(1):127~33
  • 4[5]Kim NH,Kim RI,Choi KM et al. Serum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistance. Korean J Intern Med,2000;15(3):195~201
  • 5[6]Gray RP, Panaahloo A,Mohamed AV et al. Proinsulin-like molecules and plasminogen activator type1(PAI1) activity in diabetic and non-diabetic subjects with and without myocardial infarction. Atherosclerosis,1997;130(2):171~8
  • 6[7]Hermann LS,Ranstarn J,Vaaler S et al. Effects of antihyperglycaemic therapies or proinsulin and cardiovascular risk factors in type 2 diabates. Diabetes Obes Metab,1999;1(4):227~32
  • 7[8]Rhodes CJ, Alarcon C. What beta-cell defect could lead to hyerproinsulinemia in NIDDM? Some clues from recent advance made in understanding the proinsulin-processing mechanism.Diabetes,1994;43(3):511~7
  • 8[9]Stumvoll M, Fritsche A, Stefan N et al. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. J Clin Endocrinol Metab,2001;86(3):1235~9
  • 9李光伟,胡英华,杨文英,姜亚云,曹辉碧,王金平,萧建中,胡泽溪,潘孝仁.胰岛素抵抗、胰岛素分泌功能对Ⅱ型糖尿病发生的影响[J].中华内科杂志,1998,37(9):600-604. 被引量:103

共引文献42

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部